Virginia Commonwealth University

VCU Scholars Compass
Social Work Student Works

School of Social Work

2018

Is Counseling Integral to Buprenorphine-Assisted Opioid Addiction
Treatment? Examining Counseling Participation and Treatment
Retention at a Richmond, Virginia Clinic
John R. Gyourko
Virginia Commonwealth University

Hilary Colin King
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/socialwork_student
Part of the Social Work Commons, and the Substance Abuse and Addiction Commons

Downloaded from
https://scholarscompass.vcu.edu/socialwork_student/2

This Poster is brought to you for free and open access by the School of Social Work at VCU Scholars Compass. It
has been accepted for inclusion in Social Work Student Works by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

Is Counseling Integral to Buprenorphine-Assisted Opioid Addiction Treatment?
Examining Counseling Participation and Treatment Retention at a Richmond, VA Clinic
John R. Gyourko & H. Colin King
Virginia Commonwealth University School of Social Work, Richmond, VA

Background

Results

Buprenorphine, a medication often marketed under the brand name
Suboxone, is a popular treatment for opioid use disorder (OUD).
Federal and state regulations require clinics to provide counseling
services or referrals to clients receiving buprenorphine-assisted
OUD treatment1.

Counseling type and frequency appear to have stronger effects on
retention among newer clients. Findings indicate that the
comparative benefits of counseling depend in part on client
treatment phase. While this study corroborates the importance of
psychosocial interventions for clients in buprenorphine-assisted
OUD treatment, results suggest the need for a nuanced approach
to client education and treatment planning.

Prescribing physicians widely regard counseling as a critical
component of buprenorphine treatment2, and individuals with OUD
perceive counseling to be among the most important factors
supporting recovery3.
Nearly all U.S. clinics offering buprenorphine-assisted OUD
treatment also offer individual or group counseling services4.
Research investigating the efficacy of counseling as an OUD
treatment component, however, has been equivocal to date5,6.
Additional research is needed to evaluate the comparative benefits
of counseling across varying clinical contexts.

Policy & Practice Implications
Understanding the relationships between counseling type,
frequency, and treatment length may empower clients toward
better-individualized treatment plans

Counseling type
Effect on treatment length for clients in treatment <12 months
(p=.019)

Aim
To investigate the effects of counseling on treatment retention
among clients receiving OUD treatment at the VCU Multidisciplinary
Outpatient Intensive Addiction Treatment (MOTIVATE) clinic.

Methods
Instrument
MOTIVATE clinic developed a non-standardized semi-structured
survey which was administered in Nov. 2018 to a convenience
sample of 81 clinic clients.
A secondary data set was compiled by parsing completed surveys
according to responses concerning opioid type, treatment
medication, and counseling participation.

Population
71 clients receiving buprenorphine-assisted OUD treatment
49% African American / 37% White / 3% Native American
Mean age = 45
61% female

Discussion

Results support previous research indicating that voluntary,
individualized counseling recommendations based on
treatment phase and client history are most beneficial7

Limitations

Median treatment length higher for clients in group and
concurrent counseling vs. individual counseling

Counseling frequency
Group frequency affected treatment length for clients in
treatment <12 months (p=.002)
Individual frequency affected treatment length for clients in
treatment ≥12 months (p=.046)
Total counseling frequency affected treatment length (p=.006)

Use of secondary data set restricted control over research
design and inhibited exploration of potential mediating,
moderating, and/or intervening variables
Convenience sampling & small sample size
Cross-sectional, nonexperimental design

Future Research
Counseling dynamics (group size, group cohesion, open vs.
closed types, client-clinician interactions)
Standardized survey instrument
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